Kestra Private Wealth Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $448K | Sell |
|
|||||
|
2025
Q2 | $436K | Buy |
|
|||||
|
2025
Q1 | $290K | Sell |
|
|||||
|
2024
Q4 | $377K | Buy |
|
|||||
|
2024
Q3 | $376K | Buy |
|
|||||
|
2024
Q2 | $390K | Sell |
|
|||||
|
2024
Q1 | $516K | Buy |
|
|||||
|
2023
Q4 | $448K | Buy |
|
|||||
|
2023
Q3 | $353K | Buy |
|
|||||
|
2023
Q2 | $329K | Sell |
|
|||||
|
2023
Q1 | $322K | Buy |
|
|||||
|
2022
Q4 | $331K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $466K | Sell |
|
|||||
|
2022
Q1 | $623K | Sell |
|
|||||
|
2021
Q4 | $1.79M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $1.77M | Sell |
|
|||||
|
2021
Q1 | $1.41M | Sell |
|
|||||
|
2020
Q4 | $1.61M | Sell |
|
|||||
|
2020
Q3 | $1.49M | Buy |
|